Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
32.7M
-
Shares change
-
-1.08M
-
Total reported value, excl. options
-
$306M
-
Value change
-
-$28.8M
-
Put/Call ratio
-
0.26
-
Number of buys
-
70
-
Number of sells
-
-44
-
Price
-
$9.37
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q4 2022
148 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q4 2022.
2seventy bio, Inc. - Common Stock (TSVT) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.7M shares
of 52.4M outstanding shares and own 62.33% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.05M shares), BlackRock Inc. (3.01M shares), VANGUARD GROUP INC (2.4M shares), STATE STREET CORP (2.35M shares), BAKER BROS. ADVISORS LP (2.06M shares), Casdin Capital, LLC (1.85M shares), Bain Capital Life Sciences Investors, LLC (1.41M shares), MILLENNIUM MANAGEMENT LLC (1.37M shares), Madison Avenue Partners, LP (1.2M shares), and EcoR1 Capital, LLC (1.14M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.